glp 1 for perimenopause GLP-1 use in menopause is not a shortcut to weight loss, it’s a tool to health when used appropriately. #menopause #glp1 #perimenopause #tirzepatide #semaglutide Microdosing GLP-1 in Perimenopause &

Nausea, vomiting, diarrhea, and constipation affected 60 to 80% of participants at higher doses, though most symptoms were mild to moderate in severity

In these trials, data on renal outcomes were also collected (Table 1), although not all trials had this as a prespecified outcome, and therefore the data should be interpreted with caution

Even if the drug does not decrease the symptom burden as we hope, we will learn a lot about its effects on people with Long COVID, and if it does help, Ill be beyond thrilled. Lilly contributed the doses to the trial, which is funded by the Schmidt Initiative for Long Covid, a nonprofit organization created in 2023 by philanthropists Eric and Wendy Schmidt

Adding 1 mL creates a more concentrated vial than adding 2 mL

EGFR is constitutively activated in many tumors, and evidence of a role for SELENOW in EGFR activation and signaling may help shed light on the relationship between selenium status and cancer risk (25)